- Home
- AGAE vs HSCS Comparison
AGAE vs HSCS Comparison
Compare AGAE & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGAE | HSCS |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | 73 | N/A |
| Industry | Cable & Other Pay Television Services | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 9.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AGAE | HSCS |
|---|---|---|
| Price | $0.35 | $2.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.20 |
| AVG Volume (30 Days) | ★ 9.7M | 13.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,072.41 |
| Revenue Next Year | N/A | $2,700.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $2.01 |
| 52 Week High | $3.79 | $6.47 |
Technical Indicators
Market Signals| Indicator | AGAE | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 55.87 | 43.79 |
| Support Level | $0.34 | $2.72 |
| Resistance Level | $0.44 | $3.00 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 28.44 | 19.15 |
Price Performance
Historical ComparisonAbout AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.